Skip to main content

Table 5 Results of meta-analysis in different statins groups in Western and Asian

From: The difference between Asian and Western in the effect of LDL-C lowering therapy on coronary atherosclerotic plaque: a meta-analysis report

Group Included arms (and case) Pooled SMD (95% CI,p) Heterogeneity test Sensitivity analyses Egger’s test
χ2test (p) I 2 Lower SMD (95% CI) Upper SMD (95% CI)
Western Rosuvastatin 2(869) −0.158(−0.253 ~ −0.064, 0.001) 0.18(0.672) 0 −0.142 (−0.263 ~ −0.020) Without 2006 ASTEROID Ros −0.183 (−0.332 ~ −0.035) Without 2011 SATURN Ros 0.000
Atorvastatin 2(772) −0.062(−0.162 ~ 0.038, 0.225) 0.62(0.432) 0    0.000
Pravastatin 1(249) 0.045(−0.131 ~ 0.221, 0.616)      
Simvastatin 1(40) −0.133(−0.572 ~ 0.306, 0.552)      
Asian Rosuvastatin 3(304) −0.172(−0.331 ~ −0.012, 0.035) 0.17(0.917) 0 −0.143 (−0.352 ~ 0.066) Without 2012 ARTMAP Ros −0.189 (−0.397 ~ 0.019) Without 2009 COSMOS Ros 0.660
Atorvastatin 6(366) −0.185(−0.330 ~ −0.040, 0.013) 1.94(0.858) 0 −0.113 (−0.292 ~ 0.068) Without 2009 JAPAN-ACS Ato −0.230 (−0.417 ~ −0.044) Without 2012 ARTMAP Ato 0.456
Pravastatin 2(70) −0.197(−0.529 ~ 0.135, 0.245) 0.26(0.608) 0    
Pitavastatin 1(125) −0.304(−0.553 ~ −0.055, 0.017)      
Fluvastatin 1(40) −0.169(−0.608 ~ 0.270, 0.450)      
Simvastatin 1(50) −0.074(−0.467 ~ 0.318, 0.710)      
\